Russian Pharmaceutical Industry Leader

Products

Alaget®
Pharmacotherapeutic group
Anti-HIV drug; combination antiviral drug for the treatment of HIV infections
International name
Lamivudine + Abacavir
Dosage form
Tablets
Description Manufacturer Pharmacies Leave a feedback
Combination antiviral drug. Abacavir and lamivudine are nucleoside reverse transcriptase inhibitors that potently and selectively block HIV-1 and HIV-2 replication by undergoing metabolic activation by intracellular kinases to form their respective 5'-triphosphates which act as active metabolites. Lamivudine triphosphate and carbovir triphosphate (active metabolite of abacavir) are substrates and competitive inhibitors of HIV reverse transcriptase. Their main antiviral activity is mediated by the active metabolite incorporation into viral DNA which results in blocking the viral replication.
Send
NAME AND SURNAME*
E-mail
Subject*
Message*
Captcha*
* — Required field